Nikolsky's sign

From WikiMD's Medical Encyclopedia

(Redirected from Nikolsky's Sign)


Nikolsky's sign
Synonyms
Pronounce N/A
Specialty N/A
Symptoms Skin blistering, epidermal detachment
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes Autoimmune disease, bacterial infection, toxic epidermal necrolysis
Risks N/A
Diagnosis Clinical examination
Differential diagnosis Pemphigus vulgaris, Staphylococcal scalded skin syndrome, Stevens-Johnson syndrome
Prevention N/A
Treatment Depends on underlying cause
Medication N/A
Prognosis N/A
Frequency Rare
Deaths N/A


Nikolsky's sign is a clinical dermatological sign that is indicative of skin blistering disorders, particularly those involving the epidermal layer. It is named after Pyotr Nikolsky, a Russian physician who first described it in 1896. The sign is positive when slight rubbing of the skin results in exfoliation of the outermost layer, revealing a moist, red area beneath. This is due to a loss of adhesion between skin cells, known as acantholysis.

Etiology[edit]

Nikolsky's sign is most commonly associated with pemphigus vulgaris, a rare autoimmune disorder characterized by the production of antibodies against desmoglein, a protein that facilitates cell-to-cell adhesion within the skin. Other conditions that may exhibit a positive Nikolsky's sign include Stevens-Johnson syndrome, toxic epidermal necrolysis, and staphylococcal scalded skin syndrome (SSSS). These conditions lead to varying degrees of skin and mucous membrane detachment and blistering.

Pathophysiology[edit]

The pathophysiology of Nikolsky's sign involves the disruption of desmosomes, which are structures responsible for cell-to-cell adhesion in the epidermis. In conditions like pemphigus vulgaris, autoantibodies target proteins within desmosomes, particularly desmoglein 1 and 3, leading to a loss of cell adhesion. This results in the epidermal layers easily separating upon mechanical stress, manifesting as the Nikolsky's sign.

Clinical Presentation[edit]

A positive Nikolsky's sign is elicited by applying lateral pressure to the skin, which leads to the top layer of the skin shearing off. This test is particularly performed on the perilesional skin, or skin adjacent to blisters or erosions. The presence of Nikolsky's sign indicates a high likelihood of a blistering skin disorder but is not specific to any single disease.

Diagnosis[edit]

The presence of Nikolsky's sign is an important clinical finding that prompts further diagnostic evaluation. Diagnosis of the underlying condition typically involves a combination of clinical examination, histopathology (skin biopsy), and direct immunofluorescence to identify the specific autoantibodies involved. The exact nature of the skin condition is determined based on the clinical presentation, history, and laboratory findings.

Management[edit]

Management of conditions associated with Nikolsky's sign involves addressing the underlying cause. In autoimmune conditions like pemphigus vulgaris, treatment may include systemic corticosteroids, immunosuppressants, and biologic therapies aimed at reducing antibody production. Supportive care, including wound care for blistered and eroded areas, is also crucial. The management strategy is tailored to the severity of the disease and the specific diagnosis.

Prognosis[edit]

The prognosis for patients with a positive Nikolsky's sign varies depending on the underlying condition and its response to treatment. With appropriate management, many patients can achieve disease remission. However, conditions like toxic epidermal necrolysis have a high mortality rate, emphasizing the importance of early recognition and treatment.

Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.